The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for weight loss and diabetes.

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk for a much-awaited entry into the world's most populous country grappling with increasing rates of obesity and diabetes.

Semaglutide is already available in Ireland through diabetes medication Ozempic. However, its producer Novo Nordisk uses the brand name Wegovy when it is sold as a weight-loss medication.

Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken once every week and will be available in 2.5mg and 5 mg vials. Read on to know its prices and how the weight loss drug works.

In India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar under control. At the same time, obesity is affecting around 100 million people.